17 Human immunodeficiency virus (HIV) infection is associated with various neurological manifestations in 40 to 70% of acquired immune deficiency syndrome (AIDS) patients, including primary effects of HIV, opportunistic infection, neoplasia, and vascular disease. Infections can be focal or diffuse. Cerebral toxoplasmosis is the most common mass lesion, HIV encephalopathy is the most common cause of neurological disease, and cytomegalovirus encephalitis (CMV) is the most common opportunistic viral infection found in AIDS patients. Other common infections include progressive multifocal leukoencephalopathy (PML), cryptococcal meningitis, and neurosyphilis. CMV generally has an appearance similar to primary HIV on magnetic resonance imaging (MRI) (diffuse white matter hyperintensity on T2-weighted MR sequences). However, it rarely presents as a peripherally enhancing mass, or as a necrotizing meningoencephalitis with associated subependymal enhancement, a finding that can also be seen in advanced herpes zoster, and less commonly with other herpes viruses. Another common central nervous system (CNS) lesion is primary CNS lymphoma, which has been shown to be associated with Epstein-Barr virus in almost 100% of cases. Based on MRI appearance, the lesions may be divided into When faced with white matter lesions in an AIDS patient, some features can help to differentiate HIV encephalitis from PML. They are listed in Table 17.1. The two most common enhancing intracranial masses in AIDS patients are lymphoma and toxoplasmosis. It can be difficult to differentiate the two with conventional computed tomography (CT) and MRI (Table 17.2). Fluorodeoxyglucose positron emission tomography (FDG PET) and thallium-201 single photon emission computed tomography (SPECT) are very useful in differentiating lymphoma from toxoplasmosis. Lymphoma accumulates tracer, whereas toxoplasmosis does not. The size of the lesion may play a role, with sensitivity and specificity measured at 100% and 89%, respectively, for thallium-201 SPECT for lesions ≥ 2 cm, but not meeting statistical significance for lesions <2 cm.
Intracranial Manifestations of Human Immunodeficiency Virus
Toxoplasmosis and Lymphoma
HIVE | PML | |
---|---|---|
Etiology | Direct HIV involvement |